US equities |
NVDA $239.24 ▲+0.14% MU $1,045.56 ▼-1.73% SPCX $171.92 ▲+0.49% AMD $649.42 ▲+2.80% MRVL $287.01 ▲+5.81% AVGO $375.81 ▲+3.67% INTC $112.50 ▼-3.18% MSFT $529.30 ▲+0.78%
FinancialContent

Orhub Inc (OP:ORHB)

0.0002 UNCHANGED
Delayed Quote Updated: 1:20 PM EDT, Oct 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Orhub Inc

< Previous 1 2 3 Next >
BioMedNewsBreaks – HippoFi Inc. (ORHB) Collaborates to Bring ‘Innovative Technology to the Forefront of Spinal Treatments’
Via Investor Brand Network
Topics Artificial Intelligence
News headline image
HippoFi Announces Strategic Alliance to Lead Spinal Biologics Innovation
Via ACCESSWIRE
BioMedNewsBreaks — HippoFi Inc. (ORHB) Subsidiary Granted Patent for Advanced Cartilage Regeneration and Arthritis Solutions
Via Investor Brand Network
Topics Artificial Intelligence Intellectual Property
News headline image
HippoFi's PUR Biologics Granted National Approval at the Veterans Health Administration (VHA), the Largest Integrated Healthcare System in the United States
Via ACCESSWIRE
News headline image
PUR Biologics Begins Shipment of its Breakthrough Product PURbonedough(TM)
Via ACCESSWIRE
News headline image
CORRECTION BY SOURCE: Goldman Small Cap Research Publishes New Research Report on HippoFi, Inc.
Via ACCESSWIRE
News headline image
US Patent Office Grants PUR Biologics' Breakthrough Patent for Activating Immune Cells
Via ACCESSWIRE
News headline image
US Patent Office Issues New Patent to PUR Biologics for Advanced Cartilage Regeneration and Arthritis Solutions
Via ACCESSWIRE
BioMedNewsBreaks – HippoFi Inc. (ORHB) Collaborates to Deliver One-of-a-Kind Technology Across US Market
Via Investor Brand Network
Topics Artificial Intelligence
News headline image
HippoFi Finalizes an Exclusive Strategic Partnership with International Biomedical Manufacturing Company, BPB Medica
Via ACCESSWIRE
BioMedNewsBreaks – HippoFi Inc. (ORHB) Announces Launch of PURmarrow 360, Strategic Partnership for Near-Term Commercialization of New Technology
Via Investor Brand Network
Topics Artificial Intelligence
News headline image
HippoFi Begins 2023 with Strong Sales of Advanced Biomaterials
Via ACCESSWIRE
News headline image
HippoFi’s Regenerative Therapeutics Division, Launches PURbridge(TM) for Spine Surgery
Via ACCESSWIRE
News headline image
HippoFi Signs Strategic Partnership Agreement with Precision Spine, Inc.
Via ACCESSWIRE
News headline image
HippoFi is Finalizing Definitive Agreements to Join Forces with Industry Giant to Revolutionize the Spinal Biologic Market
Via ACCESSWIRE
News headline image
HippoFi Anticipates a New Strategic Partnership as the Company Prepares to Launch PURmarrow 360, a Patented Stem Cell Harvesting Device
Via ACCESSWIRE
News headline image
PUR Biologics Expands Sales Network by 15%, Adding 32 New Distributors
Via ACCESSWIRE
News headline image
Goldman Small Cap Research Publishes New Research Report on HippoFi, Inc.
Via ACCESSWIRE
News headline image
PUR Biologics Launches PURfiberXP(TM), a Best-in-Class Cortical Fiber Matrix for Bone Regeneration
Via ACCESSWIRE
News headline image
Company Update from Executive Chairman & CEO
Via ACCESSWIRE
News headline image
ORHub Adopts New Name to Reflect Its Fintech Future - "HippoFi"
Via ACCESSWIRE
News headline image
ORHub's PUR Biologics to Launch PUR Pillars
Via ACCESSWIRE
News headline image
HippoFi Announces Its Return to a Pink Current Information Tier on the OTC Market
Via ACCESSWIRE
News headline image
PUR Biologics Announces Launch of PURcore, a bioActive Moldable Synthetic for Spine Surgery
Via ACCESSWIRE
News headline image
ORHub's PUR Biologics to Launch PUR Pillars
PUR PillarsTM were designed specifically for spine surgery, with a patient's post-surgical outcomes in mind. 
From ORHUB, Inc.
Via AccessWire
News headline image
Orhub’s Ryan Fernan Becomes Head Of Pur Biologics, Leading Regenerative Therapeutic Efforts
A proven industry leader and executive, Ryan Fernan, will help ORHub advance Ortho-Spine technology beyond current limitations. 
From ORHUB, Inc.
Via AccessWire
News headline image
Orhub’s Ryan Fernan Becomes Head Of Pur Biologics, Leading Regenerative Therapeutic Efforts
Via ACCESSWIRE
News headline image
Healthcare Innovator "ORHub" Aims to Enter the Fintech Industry
Via ACCESSWIRE
News headline image
Healthcare Innovator "ORHub" Aims to Enter the Fintech Industry
ORHub's new Surgical Resource Management ("SRM") platform, FutureOR, facilitates faster Case-to-Cash payments to medical device and biological vendors. 
From ORHUB, Inc.
Via AccessWire
News headline image
ORHub Retains Predica to Launch New Software Platform
"ORHub to launch new FutureORTM application in Q3 2022" 
From ORHUB, Inc.
Via AccessWire
Topics Artificial Intelligence
< Previous 1 2 3 Next >